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Abstract.  One of the independent factors of development of cardio-vascular 
complications is in left ventricular hypertrophy. Each year more and more publication appear 
that prove this problem is genetically determined.  
Aim  of the study was to find dependence of left ventricular hypertrophy indexes to 
polymorphism of Les198Asn gene endothelin-1 and BMI. 
Materials and methods. We took research in 160 patients with arterial hypertension, 
using ECG and polymerase chain reaction (PCR). Groups were divided additionally according 
to BMI (body mass index).  
Results. It was found, that patients with obesity had their Left ventricular mass and 
hypertrophy left ventricular indexes higher, than in patients with normal and increased body 
weight. Carriers of Asn198Asn and Lys198Asn genotypes Left ventricular mass and 
hypertrophy left ventricular indexes are higher than in carriers of Lys198Lys genotype.  
Conclusions. It was determined that in patients-carriers of Asn198Asn genotype, Left 
ventricular mass (LVMI) and hypertrophy left ventricular indexes (LVMMI) were higher 
compared to patients-carriers of Lys198Lys and Lys198Asn type, both in men and women. The 
dependence of LVMI and LVMMI are shown to be higher in patients with obesity than in 
people with normal and increased body mass.  
Key words: left ventricular hypertrophy, genes` polymorphism, endothelin-1, 
Lys198Asn genotype. 
 
           Introduction. Left ventricular hypertrophy is pathological thickening of left ventricular 
myocardium, developed in response to constant stain on heart, usually caused by chronical 
hypertension [1]. In short-term prospective this structural change leads to heart compensate 
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high hemodynamic stain. However, in long-term prospective lasting left ventricular 
hypertrophy (LVH) is an independent risk factor of development for numerous vascular 
pathological states, such as cardiac failure, ischemic heart disease, stroke, arrhythmia, sudden 
cardiac death, cardio-vascular diseases and correspondent mortality [2]. 
  LVH frequency in general population equals 3%, in case of arterial hypertension – 7 – 40% [9]. 
According to Kannel W.B. et al. LVH, diagnosted with ECG in patients with blood pressure more than 
160/95 is met 10 more often than in norma-tensive patients [3]. Increasing of left ventricular mass index 
(LVM) is possible before hypertension develops. Douglas P. et al., (2012) writes that LVH risk can be 
hereditary and cause hypertension. It is proved that increasing of blood pressure alongside with other 
factors (high body mass, age, male gender, race, neurohumoral and growth) lead to development and 
progress LVH. One of the main risk factors of LVH development is presence of comorbid diseases: 
obesity, which provokes increasing of heart afterload, 2 type diabetes. Decreasing of blood pressure, body 
mass index lead to decreasing of hypertrophy, and in the case of their absence prevents its development 
[10]. 
 Endothelin-1 (ЕТ-1) is cardiotropic that is occurred as inotropic influence on myocardium, 
regulates preload and afterload, leads to increasing of myotic process in myoradium and development of 
LVH [5-8].  
The purpose of this research was defining of indexes of intercardial and system hemodynamics in 
patients with arterial hypertension, according to polymorphism of Lys198Asn gene endothelin-1. 
Question of implement of current polymorphism factor on LVH level is relevant and requires further 
studying to improve treatment tactics. 
Aim. Detection of LVH indexes dependence in patients with arterial hypertension from 
polymorphism Lys198Asn gene endothelin-1 and body mass index. 
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Materials and methods 
160 patients with vary arterial hypertension diagnoses of І, ІІ phases 1, 2, 3 levels were 
examined during the study. Among examined patients were 83 women (51,9 %) and 77 men 
(48,1%) at the age of 33 – 87 years, median (interquartile range) – 67 (58 ̶ 67) years. All patients 
were divided into 3 groups, depending of BMI. І group – BMI < 24,9 kg/m²; ІІ group – BMI = 
25,0 – 29,9 kg/m²; ІІІ group – BMI > 30,0 kg/m².  І group consisted of  75 patients, in which 
41 women (54,7%) and 34 men (45,3 %). Age range of examined patients in І group equaled 
68 (60–75) years. In ІІ group were 48 patients, in which  20 women (58,3%) and 28 men 
(41,7%). Age range of examined persons in ІІ group was 65 (54–76) years. In ІІІ  group  37 
patients were included, 22 women (59,5%) and 15 men ( 40,5%). Age range of examined 
patients of ІІІ group was 65 (60–77) years. 
Dividing of groups according to BMI means anthropometric data varies with statistically 
significant range of BMI (р < 0,05, Kruskal-Wallis).  Patients with obesity had following  
circumference of waist: in women 103 (96-115) cm, in men 108 (105–116) cm, that indicated 
abdominal type of obesity.  
With ECG analysis, we studied left ventricular end-diastolic dimension (LVEDd), 
thickness of the interventricular septum (TIS), PWT in M-mode from parasternal access at the 
level of mitral valve chord along cardial long axis. Left ventricular myocardium mass (LVMM) 
was calculated by formula Penn Convention: LVMM = 1,06 × {[EDD + DLVPWT + ISTD]3 
– EDD3} – 13,6 (g). To calculate LVMMI we used formula, recommended by ASE (American 
Society of Echocardiography) (2005): LVMMI = LVMM/height²˒⁷. To confirm the diagnosis 
of LVH we examined and compared ECG data: LVMM in women >162 g, inmen >224 g; 
LVMMI in women >44 g/m²˒⁷, in men >48 g/m2,7 [13]. Polymorphism of Lys198Asn gene of 
endothelin-1 was identified with  polymerase chain reaction with further analysis of 
restriction fragments. Data were statistically processed with non-parametric methods, as 
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division of LVMM (left ventricular myocardium mass) and HLVMM (hypertrophy left 
ventricular myocardium mass) indexes  by Gauss were not equal to normal. For description of 
LVMM and HLMM  we used median data and interquartile range (25th and 75th percentiles). 
To compare mentioned indexes we used rankings` analysis variation ANOVA by Kruskal-
Wallis criteria. Using of this method we checked null hypothesis for absence of difference 
between groups. If p>0,05, than null hypothesis about median difference absence in groups was 
proved, that means groups were not different. If p<0,05, null hypothesis was not proved, and, 
correspondently, we got alternative hypothesis that proved median difference in groups.  In the 
last case, we compared groups in pairs with non-parametric Mann-Whitney U-test and 
Bonferroni correction to evaluation of  р-value. 
Patients were enrolled in the study after informed consent obtained in accordance with 
the Helsinki Declaration of the World Medical Association on the Ethical Principles of 
Scientific and Medical Research. The study was approved by the Bioethics Committee for 
experimental and clinical studies at Sumy State University Medical Institute. 
 
Results 
At the first stage we analyzed dependence of ECG data from polymorphism Lys198Asn 
gene of endothelin-1 (Table I).  
 
Table І 
Median (interquartile range) of ECG indexes of left ventricular myocardium 
hypertrophy in patients with arterial hypertension, depending on polymorphism 
Lys198Asn in gene endothelin-1. 
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       Indicators 
Genotype 
Mass of myocardium of left 
ventricle, g 
 
Left ventricular myocardial mass 
index, g/m²˒⁷ 
Lys198Lys (n=74) 243 ( 183  ̶  300) 73 (42  ̶  88) 
Lys198Asn (n=73) 290 (201  ̶  332) 81 (47  ̶  90) 
  (n=13) 320 (285  ̶  360) 89 (84  ̶  94) 
р (Kruskel-Wallis) р < 0,003 р = 0,008 
 
The results proved that data of LVMM and LVMMI in patents with arterial hypertension 
and different genotype polymorphism of Lys198Asn of gene endothelin-1 (р₁ = 0,003; р₂ = 
0,008, Kruskel-Wallis). Carriers of Asn198Asn genotype LVMM is 24% higher than in patients 
with Lys198Lys type (р = 0,001, Mann-Whitney). Patients with hypertension and Lys198Asn  
genotype LVMM was 9% higher to Lys198Lys type (р = 0,021, Mann-Whitney). The same 
tendency is observed among carriers of Lys198Asn and Asn198Asn types, though, it had not 
been statistically significant (р = 0,136, Mann-Whitney). LVMMI in patients with Asn198Asn 
genotype is higher compared to data of patients-carriers of Lys198Lys type for 17% (р = 0,007, 
Mann-Whitney) and 9% higher in Lуs198Asn carriers compared to Lys198Lys ones (р = 0,028, 
Mann-Whitney). Between carriers of Lys198Asn and Asn198Asn genotypes difference was not 
statistically significant (р = 0,121, Mann-Whitney).  
Next phase was checking difference existence of LVMM and LVMMI in men and 
women depending on genotype polymorphism of  Lys198Asn of gene endothelin-1. It is 
determined that there is difference of LVMM and LVMMI in men depending of genotype (р₁ 
= 0,002; р₂ = 0,010, Kruskel-Wallis). After comparison according to Mann-Whitney method,it 
was determined that in men-carriers of Asn198Asn genotype LVMM is 31% higher that in 
representatives of  Lys198Lys type (р = 0,002, Mann-Whitney). In patients-men with 
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hypertension and Lys198Asn genotype LVMM is 27% higher comparing to Lys198Lys (р = 
0,005, Mann-Whitney). In carriers of Lys198Asn and Asn198Asn genotypes diffrenve was not 
statistically significant (р = 0,394, Mann-Whitney). LVMMI analysis in men with different 
genotype polymorphism of  Lys198Asn of gene endothelin-1 it was determined that in men-
carriers of Asn198Asn type LVMMI is 50% higher than in patients with Lys198Lys (р = 0,010, 
Mann-Whitney). In cariers of Lys198Asn genotype LVMMI was higher compared to patients 
with Lys198Lys for 41% (р = 0,021, Mann-Whitney). In patients with arterial hypertension 
with genotypes Lys198Asn and Asn198Asn difference in LVMMI was not registered (р = 
0,223, Mann-Whitney) (Fig. 1). 
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Fig. 1. Median (interquartile range) of ECG indexes in men depending on polymorphism of  
Lys198Asn in gene endothelin-1. 
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           We additionally checked difference presence of LVMM and LVMMI in women with 
hypertension depending of genotype polymorphism of Lys198Asn of gene endothelin-1. It was 
found, that difference is typical for women either (р₁ = 0,004; р₂ = 0,010, Kruskel-Wallis). In 
women-carriers of Asn198Asn genotype LVMM is 44% higher than in patients with 
Lys198Lys (р = 0,046, Mann-Whitney). In women with arterial hypertension and Lys198Asn 
genotype LVMM was higher for 26% compared to Lys198Lys type (р = 0,002, Mann-
Whitney). In carriers of Lys198Asn and Asn198Asn types difference had not been statistically 
significant (р = 0,547, Mann-Whitney). LVMMI in women with Asn198Asn genotype is for 
54% higher than in representatives of Lys198Lys genotype (р = 0,004, Mann-Whitney). In 
patients-women with hypertension with Lys198Asn genotype LVMMI was higher compared 
to Lys198Lys genotype for 43 % (р = 0,005, Mann-Whitney).  In women with hypertension 
and genotypes Lys198Asn and Asn198Asn difference in LVMMI was not registered (р = 0,460, 
Mann-Whitney) (Fig. 2). 
  
Fig. 2. Median (interquartile range) of ECG indexes in women depending on polymorphism of  
Lys198Asn in gene endothelin-1. 
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Alongside with studying dependence of ECG data from Lys198Asn polymorphism, we 
took research on dependence of these data from BMI (Table II). 
 
Table ІІ. 
Median (interquartile range) of ECG indexes of left ventricular myocardium hypertrophy in 
patients with arterial hypertension, depending on body mass index. 
       Indicators 
Group 
Mass of myocardium of left 
ventricle, g 
 
Left ventricular myocardial 
mass index, g/m²˒⁷ 
І group (n=75) 264 ( 198  ̶  300) 76 (42  ̶  88) 
ІІ group (n=48) 267 (200  ̶  319) 79 (44  ̶  89) 
ІІІ group (n=37) 320 (240  ̶  390) 86 (54  ̶  95) 
р (Kruskel-Wallis) р < 0,001 р = 0,002 
 
Results` analysis showed presence of difference of LVMM and LVMMI data according 
to studied groups (р₁ < 0,001; р₂ = 0,002, Kruskel-Wallis). In ІІІ group patients LVMM data 
were 18% and 16% higher than in patients of  І and ІІ groups correspondently (р₁ < 0,001; р₂ = 
0,004, Mann-Whitney). Difference between results of І and ІІ groups were not statistically 
significant (р = 0,260, Mann-Whitney). LVMMI in patients of ІІІ group is 11% higher 
compared to results of І group (р < 0,001, Манна-Уітні) and 8% compared to ІІ (р = 0,026, 
Mann-Whitney). ). Difference between results of І and ІІ groups were not statistically 
significant (р = 0,218, Mann-Whitney). 
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 We also studied dependence of LVMM and LVMMI from BMI in men. It was proved 
that both indexes differ by the formed by BMI group for study (р₁ < 0,001; р₂ = 0,001, Kruskel-
Wallis). LVMM in ІІІ group is 45% higher compared to І (р < 0,001, Mann-Whitney), in ІІ 
group index is 24% increased compared to the same group (р < 0,050, Mann-Whitney). In ІІІ 
group LVMM is 25% increased compared to LVMM in ІІ (р = 0,003, Mann-Whitney). LVMMI 
in ІІІ group is higher for 53% and 16% correspondently compared to І and ІІ groups (р₁ < 0,001, 
р₂ = 0,004, Mann-Whitney), in ІІ group current index is also increased compared to І, however, 
this difference is not statistically significant (р = 0,237, Mann-Whitney) (Fig. 3). 
   
Fig. 3. Median (interquartile range) of ECG indexes of left ventricular myocardium hypertrophy 
in men with arterial hypertension, depending on BMI.  
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difference is not statistically significant (р = 0,442, Mann-Whitney). LVMMI in ІІІ group was 
53% increased compared to I group (р = 0,005, Mann-Whitney), in ІІ group current index is 
increased compared to І for 41% (р = 0,014, Mann-Whitney). During comparison of results in 
ІІ and ІІІ groups significant difference was not registered (р = 0,256, Mann-Whitney) (Fig. 4). 
   
Fig. 4. Median (interquartile range) of ECG indexes of left ventricular myocardium hypertrophy 
in women with arterial hypertension, depending on BMI. 
Discussion 
In clinical research of polymorphic types of gene EDN-1 that influence incresasoing of 
cardio-vascular diseases risk, we found that polymorphism of Lys198Asn gene of endothelin-1 
is met more often. It is located in chromosome 6р24­р23 and includes 5 exons and 4 introns. 
Replacing of guanine to thymine in position 594 of nucleotide sequence (594G > T) leads to 
replacing of amino-acid lysine (Lys) to asparagine (Asn) in codon of 198 polypeptide 
(Lys198Asn), and changes protein structure and activity [11, 12]. Studying of polymorphic 
types of Lys198Asn gene of  EDN-1 was carried in cases of arterial hypertension, coronary 
heart disease (CHD),  chronic heart failure (CHF), blood-strokes, myocardial infraction. 
201
272
240
301
352
457
220
310
390
0
50
100
150
200
250
300
350
400
450
500
І group ІІ group ІІІ group
min max med
41
71
58
90 91
108
46
86
98
0
20
40
60
80
100
120
І group ІІ group ІІІ group
min max med
13 
 
Current study was aimed to determine interconnection of gene`s difference with heart diseases` 
frequency, influence on disease mechanism, complications, progress, medical prognosis. 
Numerous previous studies proved dependence of genotype Asn198Asn, allele Asn and 
increased indexes of ЕТ­1 in blood, and lead us to believe that contingent of patients-carriers 
of allele Asn is a group of high cardio-vascular diseases risk [13, 14, 15, 16]. 
  There are not much researches and studies of influence of polymorphism Lys198Asn 
of gene endothelin-1 in development of left ventricular myocardium hypertrophy, changes of 
heart sizes and cavity volume, in other words, process of myocardium remodeling, presented.   
Palagnyuk GO, Zhebel' VM (2016) studied how carriage of allele Asn in patients with non-
complicated hypertonia and complicated CHF was associated with negative changes of indexes 
of myocardium hypertrophy, left ventricular volume, LVEF, total peripheral resistance, 
diastolic function, systolic blood pressure, diastolic blood pressure, that increased 
correspondently to hypertension complication. Authors consider that patients with arterial 
hypertension, and carriers of allele Asn of gene endothelin-1 have negative prognosis of cardio 
disease and risk of CHF development [16]. Petyunina OV, Kopytsya MP (2018) studied 
clinical-genetic aspects of association of polymorphism of Lys198Asn of gene endothelin-1 
with development of early and late myocardium remodeling after suffering acute myocardial 
infraction  with elevation of ST (AMIeST). In acuity of AMIеST structural and functional 
indexes of myocardium depending on Lys198Asn polymorphism of gene endothelin-1 were not 
changed. In 6 months carriers of genotypes Lys198Asn + Asn198Asn compared to ones with 
genotype Lys198Lys had increasing of size and left ventricular volume, LVMM, diameter of 
left auricle, thus, predisposition of progressive myocardium remodeling and CHF development 
were evidenced [17]. М.Colombo et al. (2006) studied dependence of Lys198Asn 
polymorphism of gene endothelin-1 and H323H of gene ЕТ-А receptors with development of 
CHF in patients with LVEF ≤ 40%. CHF risk was increasing in carriers of genotype Asn198Asn 
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compared to allele Lys (OR = 3,2; р = 0,03). In combination of carriage of homozygote  
Asn198Asn polymorphism of gene endothelin-1 and ТТ of gene ЕТ-А CHF risk was highly 
increased (OR = 8,6; р = 0,005), that led to decreasing of FVC and increasing of EDD compared 
to patients-carriers of homozygotes Lys and С of correspondent genes [18]. Correlation of allele 
Asn of gene endothelin-1 with left ventricular hypertrophy and arterial hypertension was also 
found in other studies  [19, 20, 21]. 
Conclusions 
Analysis of dependence of ECG indexes from polymorphism of Lys198Asn of gene 
endothelin-1 allowed to determine that in patients-carriers of genotype Asn198Asn, LFMMI 
and LVMM are higher than in carriers of genotype Lys198Lys and Lys198Asn both in men and 
women. Analysis result of dependence of LVMMI and LVMM from BMI demonstrated that in 
patients with obesity these indexes are higher compared to patients with increased and normal 
body mass. Prospective of further research is determination of influence of mentioned 
polymorphism types on effectiveness of anti-hypertension therapy and decreasing of LVH 
level.  
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